TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs6914864
log Bayes Factor = 52.5732
Chromosome 6   position 27,336,489  (GRCh37) Explore rs6914864 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E83.1 Disorders of iron metabolism
1.000 0.000 0.000
K90.0 Coeliac disease
0.000 0.000 1.000
K90 Intestinal malabsorption
0.000 0.441 0.559
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.493 0.507
K90.3 Pancreatic steatorrhoea
0.000 0.599 0.401
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.599 0.401
K90.1 Tropical sprue
0.000 0.599 0.401
K90.9 Intestinal malabsorption, unspecified
0.000 0.630 0.370
K90.8 Other intestinal malabsorption
0.000 0.685 0.315
E83 Disorders of mineral metabolism
0.252 0.748 0.000
E83.3 Disorders of phosphorus metabolism
0.201 0.799 0.000
E83.9 Disorder of mineral metabolism, unspecified
0.190 0.810 0.000
E83.8 Other disorders of mineral metabolism
0.181 0.819 0.000
E83.2 Disorders of zinc metabolism
0.181 0.819 0.000
E83.0 Disorders of copper metabolism
0.181 0.819 0.000
E83.4 Disorders of magnesium metabolism
0.129 0.871 0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.102 0.898 0.000
E70-E90 Metabolic disorders
0.101 0.899 0.000
E88 Other metabolic disorders
0.101 0.899 0.000
E80 Disorders of porphyrin and bilirubin metabolism
0.093 0.907 0.000
E85 Amyloidosis
0.087 0.913 0.000
E80.4 Gilbert's syndrome
0.084 0.916 0.000
E88.3 Tumour lysis syndrome
0.081 0.919 0.000
E80.1 Porphyria cutanea tarda
0.080 0.920 0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.079 0.921 0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.076 0.924 0.000
E85.9 Amyloidosis, unspecified
0.075 0.924 0.000
E88.8 Other specified metabolic disorders
0.075 0.925 0.000
E77 Disorders of glycoprotein metabolism
0.073 0.927 0.000
E76 Disorders of glycosaminoglycan metabolism
0.073 0.927 0.000
E72 Other disorders of amino-acid metabolism
0.073 0.927 0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.073 0.927 0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.073 0.927 0.000
E88.1 Lipodystrophy, not elsewhere classified
0.071 0.929 0.000
E70 Disorders of aromatic amino-acid metabolism
0.070 0.930 0.000
E84 Cystic fibrosis
0.069 0.931 0.000
E85.8 Other amyloidosis
0.068 0.932 0.000
E88.2 Lipomatosis, not elsewhere classified
0.067 0.933 0.000
E80.7 Disorder of bilirubin metabolism, unspecified
0.067 0.933 0.000
E80.5 Crigler-Najjar syndrome
0.067 0.933 0.000
E80.3 Defects of catalase and peroxydase
0.067 0.933 0.000
E80.0 Hereditary erythropoietic porphyria
0.067 0.933 0.000
E80.6 Other disorders of bilirubin metabolism
0.066 0.934 0.000
E89.4 Postprocedural ovarian failure
0.064 0.935 0.000
E73 Lactose intolerance
0.063 0.937 0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.063 0.937 0.000
E79 Disorders of purine and pyrimidine metabolism
0.063 0.937 0.000
E85.2 Heredofamilial amyloidosis, unspecified
0.062 0.938 0.000
E85.1 Neuropathic heredofamilial amyloidosis
0.062 0.938 0.000
E85.0 Nonneuropathic heredofamilial amyloidosis
0.062 0.938 0.000
E85.3 Secondary systemic amyloidosis
0.062 0.938 0.000
E74 Other disorders of carbohydrate metabolism
0.061 0.939 0.000
E80.2 Other porphyria
0.061 0.939 0.000
E88.9 Metabolic disorder, unspecified
0.059 0.941 0.000
E75.2 Other sphingolipidosis
0.059 0.941 0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.057 0.943 0.000
E89.8 Other postprocedural endocrine and metabolic disorders
0.057 0.943 0.000
E89.5 Postprocedural testicular hypofunction
0.057 0.943 0.000
E89.1 Postprocedural hypoinsulinaemia
0.057 0.943 0.000
E85.4 Organ-limited amyloidosis
0.057 0.943 0.000
E89.0 Postprocedural hypothyroidism
0.055 0.945 0.000
E75.6 Lipid storage disorder, unspecified
0.054 0.945 0.000
E75.4 Neuronal ceroid lipofuscinosis
0.054 0.945 0.000
E75.3 Sphingolipidosis, unspecified
0.054 0.945 0.000
E75.1 Other gangliosidosis
0.054 0.945 0.000
E75.0 GM2 gangliosidosis
0.054 0.945 0.000
E89.3 Postprocedural hypopituitarism
0.053 0.947 0.000
E71.3 Disorders of fatty-acid metabolism
0.052 0.948 0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.052 0.948 0.000
E71.1 Other disorders of branched-chain amino-acid metabolism
0.052 0.948 0.000
E71.0 Maple-syrup-urine disease
0.052 0.948 0.000
E72.9 Disorder of amino-acid metabolism, unspecified
0.052 0.948 0.000
E72.8 Other specified disorders of amino-acid metabolism
0.052 0.948 0.000
E72.5 Disorders of glycine metabolism
0.052 0.948 0.000
E72.4 Disorders of ornithine metabolism
0.052 0.948 0.000
E72.3 Disorders of lysine and hydroxylysine metabolism
0.052 0.948 0.000
E72.2 Disorders of urea cycle metabolism
0.052 0.948 0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.052 0.948 0.000
E72.0 Disorders of amino-acid transport
0.052 0.948 0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.052 0.948 0.000
E76.8 Other disorders of glucosaminoglycan metabolism
0.052 0.948 0.000
E76.3 Mucopolysaccharidosis, unspecified
0.052 0.948 0.000
E76.2 Other mucopolysaccharidoses
0.052 0.948 0.000
E76.1 Mucopolysaccharidosis, type II
0.052 0.948 0.000
E76.0 Mucopolysaccharidosis, type I
0.052 0.948 0.000
E77.9 Disorder of glycoprotein metabolism, unspecified
0.052 0.948 0.000
E77.8 Other disorders of glycoprotein metabolism
0.052 0.948 0.000
E77.1 Defects in glycoprotein degradation
0.052 0.948 0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.052 0.948 0.000
E75.5 Other lipid storage disorders
0.052 0.948 0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.050 0.949 0.000
E70.8 Other disorders of aromatic amino-acid metabolism
0.050 0.949 0.000
E70.2 Disorders of tyrosine metabolism
0.050 0.949 0.000
E70.1 Other hyperphenylalaninaemias
0.050 0.949 0.000
E70.0 Classical phenylketonuria
0.050 0.949 0.000
E89.2 Postprocedural hypoparathyroidism
0.050 0.950 0.000
E84.8 Cystic fibrosis with other manifestations
0.050 0.950 0.000
E84.1 Cystic fibrosis with intestinal manifestations
0.050 0.950 0.000
E84.0 Cystic fibrosis with pulmonary manifestations
0.050 0.950 0.000
E70.3 Albinism
0.048 0.952 0.000
E84.9 Cystic fibrosis, unspecified
0.046 0.954 0.000
E73.8 Other lactose intolerance
0.046 0.954 0.000
E73.1 Secondary lactase deficiency
0.046 0.954 0.000
E73.0 Congenital lactase deficiency
0.046 0.954 0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.045 0.954 0.000
E79.8 Other disorders of purine and pyrimidine metabolism
0.045 0.954 0.000
E79.1 Lesch-Nyhan syndrome
0.045 0.954 0.000
E74.9 Disorder of carbohydrate metabolism, unspecified
0.044 0.956 0.000
E74.8 Other specified disorders of carbohydrate metabolism
0.044 0.956 0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.044 0.956 0.000
E74.2 Disorders of galactose metabolism
0.044 0.956 0.000
E74.1 Disorders of fructose metabolism
0.044 0.956 0.000
E74.0 Glycogen storage disease
0.044 0.956 0.000
K90-K93 Other diseases of the digestive system
0.000 0.962 0.038
E73.9 Lactose intolerance, unspecified
0.036 0.964 0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.036 0.964 0.000
E74.3 Other disorders of intestinal carbohydrate absorption
0.032 0.967 0.000
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand
0.000 0.968 0.032
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.973 0.027
K07.3 Anomalies of tooth position
0.000 0.973 0.027
K07 Dentofacial anomalies [including malocclusion]
0.000 0.980 0.020
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.980 0.020
K93.1 Megacolon in Chagas' disease
0.000 0.980 0.020
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.980 0.020
T42.4 Benzodiazepines
0.020 0.980 0.000
K07.4 Malocclusion, unspecified
0.000 0.981 0.019
K07.9 Dentofacial anomaly, unspecified
0.000 0.982 0.018
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.018 0.982 0.000
M72.0 Palmar fascial fibromatosis [Dupuytren]
0.000 0.983 0.017
T42.0 Hydantoin derivatives
0.017 0.983 0.000
E83.5 Disorders of calcium metabolism
0.017 0.983 0.000
K07.2 Anomalies of dental arch relationship
0.000 0.984 0.016
T36-T50 Poisoning by drugs, medicaments and biological substances
0.015 0.985 0.000
T39.1 4-Aminophenol derivatives
0.015 0.985 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.015 0.985 0.000
K07.6 Temporomandibular joint disorders
0.000 0.985 0.015
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.014 0.985 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.014 0.986 0.000
K07.5 Dentofacial functional abnormalities
0.000 0.986 0.014
E05.9 Thyrotoxicosis, unspecified
0.000 0.986 0.014
K07.0 Major anomalies of jaw size
0.000 0.986 0.013
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.014 0.986 0.000
K07.1 Anomalies of jaw-cranial base relationship
0.000 0.987 0.013
T42.5 Mixed antiepileptics, not elsewhere classified
0.013 0.987 0.000
T42.3 Barbiturates
0.013 0.987 0.000
T42.2 Succinimides and oxazolidinediones
0.013 0.987 0.000
T40.2 Other opioids
0.013 0.987 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.013 0.987 0.000
M72.08 Palmar fascial fibromatosis [Dupuytren]-Other
0.000 0.987 0.012
M72.07 Palmar fascial fibromatosis [Dupuytren]-Ankle/Foot
0.000 0.987 0.012
M72.06 Palmar fascial fibromatosis [Dupuytren]-Lower Leg
0.000 0.987 0.012
M72.05 Palmar fascial fibromatosis [Dupuytren]-Pelvic/Thigh
0.000 0.987 0.012
M72.03 Palmar fascial fibromatosis [Dupuytren]-Forearm
0.000 0.987 0.012
M72.02 Palmar fascial fibromatosis [Dupuytren]-Upper arm
0.000 0.987 0.012
M72.01 Palmar fascial fibromatosis [Dupuytren]-Shldr region
0.000 0.987 0.012
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.013 0.987 0.000
K07.8 Other dentofacial anomalies
0.000 0.987 0.012
M72.09 Palmar fascial fibromatosis [Dupuytren]-Site unspec
0.000 0.988 0.012
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.012 0.988 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.012 0.988 0.000
T50.8 Diagnostic agents
0.012 0.988 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.012 0.988 0.000
M72.00 Palmar fascial fibromatosis [Dupuytren]-Mult sites
0.000 0.988 0.012
T50.4 Drugs affecting uric acid metabolism
0.012 0.988 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.012 0.988 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.012 0.988 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.012 0.988 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.011 0.988 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.011 0.989 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.011 0.989 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.011 0.989 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.011 0.989 0.000
F41.9 Anxiety disorder, unspecified
0.011 0.989 0.000
E86 Volume depletion
0.011 0.989 0.000
T39.4 Antirheumatics, not elsewhere classified
0.011 0.989 0.000
T39.2 Pyrazolone derivatives
0.011 0.989 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.010 0.990 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.010 0.990 0.000
T50.7 Analeptics and opioid receptor antagonists
0.010 0.990 0.000
T50.5 Appetite depressants
0.010 0.990 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.010 0.990 0.000
T50.1 Loop [high-ceiling] diuretics
0.010 0.990 0.000
T50.0 Mineralocorticoids and their antagonists
0.010 0.990 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.010 0.990 0.000
T42.1 Iminostilbenes
0.010 0.990 0.000
T39.0 Salicylates
0.010 0.990 0.000
T36 Poisoning by systemic antibiotics
0.010 0.990 0.000
G24.3 Spasmodic torticollis
0.010 0.990 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.010 0.990 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.009 0.990 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.009 0.991 0.000
T37.5 Antiviral drugs
0.009 0.991 0.000
T37.4 Anthelminthics
0.009 0.991 0.000
T37.3 Other antiprotozoal drugs
0.009 0.991 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.009 0.991 0.000
T37.1 Antimycobacterial drugs
0.009 0.991 0.000
T37.0 Sulphonamides
0.009 0.991 0.000
T40.1 Heroin
0.009 0.991 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.009 0.991 0.000
G24 Dystonia
0.009 0.991 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.009 0.991 0.000
T40.8 Lysergide [LSD]
0.009 0.991 0.000
T40.7 Cannabis (derivatives)
0.009 0.991 0.000
T40.3 Methadone
0.009 0.991 0.000
T40.0 Opium
0.009 0.991 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.009 0.991 0.000
G24.9 Dystonia, unspecified
0.009 0.991 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.009 0.991 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.009 0.991 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.009 0.991 0.000
T48.5 Anti-common-cold drugs
0.009 0.991 0.000
T48.4 Expectorants
0.009 0.991 0.000
T48.3 Antitussives
0.009 0.991 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.009 0.991 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.009 0.991 0.000
T48.0 Oxytocic drugs
0.009 0.991 0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture
0.009 0.991 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.009 0.991 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.009 0.991 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.009 0.991 0.000
T47.7 Emetics
0.009 0.991 0.000
T47.6 Antidiarrhoeal drugs
0.009 0.991 0.000
T47.5 Digestants
0.009 0.991 0.000
T47.4 Other laxatives
0.009 0.991 0.000
T47.3 Saline and osmotic laxatives
0.009 0.991 0.000
T40.5 Cocaine
0.009 0.991 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.009 0.991 0.000
T47.2 Stimulant laxatives
0.009 0.991 0.000
T38.9 Other and unspecified hormone antagonists
0.009 0.991 0.000
T38.7 Androgens and anabolic congeners
0.009 0.991 0.000
T38.5 Other oestrogens and progestogens
0.009 0.991 0.000
T38.4 Oral contraceptives
0.009 0.991 0.000
T38.2 Antithyroid drugs
0.009 0.991 0.000
T38.0 Glucocorticoids and synthetic analogues
0.009 0.991 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.009 0.991 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.009 0.991 0.000
T46.7 Peripheral vasodilators
0.009 0.991 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.009 0.991 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.008 0.991 0.000
T47.0 Histamine H(2)-receptor antagonists
0.008 0.991 0.000
T41.5 Therapeutic gases
0.008 0.992 0.000
T41.4 Anaesthetic, unspecified
0.008 0.992 0.000
T41.3 Local anaesthetics
0.008 0.992 0.000
T41.2 Other and unspecified general anaesthetics
0.008 0.992 0.000
T41.1 Intravenous anaesthetics
0.008 0.992 0.000
T41.0 Inhaled anaesthetics
0.008 0.992 0.000
T49.9 Topical agent, unspecified
0.008 0.992 0.000
T49.8 Other topical agents
0.008 0.992 0.000
T49.7 Dental drugs, topically applied
0.008 0.992 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.008 0.992 0.000
T49.5 Ophthalmological drugs and preparations
0.008 0.992 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.008 0.992 0.000
T49.3 Emollients, demulcents and protectants
0.008 0.992 0.000
T49.2 Local astringents and local detergents
0.008 0.992 0.000
T49.1 Antipruritics
0.008 0.992 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.008 0.992 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.008 0.992 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.008 0.992 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.008 0.992 0.000
T38.1 Thyroid hormones and substitutes
0.008 0.992 0.000
K63.1 Perforation of intestine (nontraumatic)
0.000 0.992 0.008
G24.8 Other dystonia
0.008 0.992 0.000
M72 Fibroblastic disorders
0.000 0.992 0.008
T40.6 Other and unspecified narcotics
0.008 0.992 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.008 0.992 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.008 0.992 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.008 0.992 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.008 0.992 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.008 0.992 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.008 0.992 0.000
T44.0 Anticholinesterase agents
0.008 0.992 0.000
G24.5 Blepharospasm
0.008 0.992 0.000
T36.4 Tetracyclines
0.007 0.992 0.000
T36.3 Macrolides
0.007 0.993 0.000
T36.9 Systemic antibiotic, unspecified
0.007 0.993 0.000
T36.8 Other systemic antibiotics
0.007 0.993 0.000
T36.7 Antifungal antibiotics, systemically used
0.007 0.993 0.000
T36.6 Rifamycins
0.007 0.993 0.000
T36.5 Aminoglycosides
0.007 0.993 0.000
T36.2 Chloramphenicol group
0.007 0.993 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.007 0.993 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.007 0.993 0.000
C71.1 Frontal lobe
0.000 0.993 0.007
G24.4 Idiopathic orofacial dystonia
0.007 0.993 0.000
G24.2 Idiopathic nonfamilial dystonia
0.007 0.993 0.000
G24.1 Idiopathic familial dystonia
0.007 0.993 0.000
G24.0 Drug-induced dystonia
0.007 0.993 0.000
I83.9 Varicose veins of lower extremities without ulcer or inflammation
0.007 0.993 0.000
T45.2 Vitamins, not elsewhere classified
0.007 0.993 0.000
T46.1 Calcium-channel blockers
0.007 0.993 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.006 0.993 0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified
0.000 0.993 0.007
Q21.9 Congenital malformation of cardiac septum, unspecified
0.006 0.993 0.000
M72.2 Plantar fascial fibromatosis
0.000 0.994 0.006
C71 Malignant neoplasm of brain
0.000 0.994 0.006
T45.9 Primarily systemic and haematological agent, unspecified
0.006 0.994 0.000
T45.8 Other primarily systemic and haematological agents
0.006 0.994 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.006 0.994 0.000
T45.6 Fibrinolysis-affecting drugs
0.006 0.994 0.000
T45.4 Iron and its compounds
0.006 0.994 0.000
T45.3 Enzymes, not elsewhere classified
0.006 0.994 0.000
C71.2 Temporal lobe
0.000 0.994 0.006
C71.0 Cerebrum, except lobes and ventricles
0.000 0.994 0.006
Q21 Congenital malformations of cardiac septa
0.006 0.994 0.000
J45.0 Predominantly allergic asthma
0.006 0.994 0.000
M72.5 Fasciitis, not elsewhere classified
0.000 0.994 0.006
M72.9 Fibroblastic disorder, unspecified
0.000 0.994 0.006
M72.8 Other fibroblastic disorders
0.000 0.994 0.006
M72.6 Necrotizing fasciitis
0.000 0.994 0.006
M72.4 Pseudosarcomatous fibromatosis
0.000 0.994 0.006
M72.3 Nodular fasciitis
0.000 0.994 0.006
J06.9 Acute upper respiratory infection, unspecified
0.006 0.994 0.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection
0.006 0.994 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.005 0.994 0.000
K91.1 Postgastric surgery syndromes
0.000 0.994 0.006
T40.4 Other synthetic narcotics
0.005 0.994 0.000
M72.1 Knuckle pads
0.000 0.994 0.005
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.005 0.995 0.000
Q21.0 Ventricular septal defect
0.005 0.995 0.000
Q25 Congenital malformations of great arteries
0.005 0.995 0.000
M72.27 Plantar fascial fibromatosis-Ankle/Foot
0.000 0.995 0.005
Q21.8 Other congenital malformations of cardiac septa
0.005 0.995 0.000
C09.9 Tonsil, unspecified
0.000 0.995 0.005
T45.5 Anticoagulants
0.005 0.995 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.005 0.995 0.000
Q25.4 Other congenital malformations of aorta
0.005 0.995 0.000
T36.0 Penicillins
0.005 0.995 0.000
M41.96 Scoliosis, unspecified (Lumbar region)
0.000 0.995 0.005
R27.0 Ataxia, unspecified
0.005 0.995 0.000
K91.9 Postprocedural disorder of digestive system, unspecified
0.000 0.995 0.005
C71.4 Occipital lobe
0.000 0.995 0.005
M20.5 Other deformities of toe(s) (acquired)
0.005 0.995 0.000
Q25.1 Coarctation of aorta
0.005 0.995 0.000
Q25.6 Stenosis of pulmonary artery
0.005 0.995 0.000
M72.29 Plantar fascial fibromatosis-Site unspec
0.000 0.995 0.005
M72.28 Plantar fascial fibromatosis-Other
0.000 0.995 0.005
M72.26 Plantar fascial fibromatosis-Lower Leg
0.000 0.995 0.005
M72.25 Plantar fascial fibromatosis-Pelvic/Thigh
0.000 0.995 0.005
M72.24 Plantar fascial fibromatosis-Hand
0.000 0.995 0.005
M72.23 Plantar fascial fibromatosis-Forearm
0.000 0.995 0.005
M72.22 Plantar fascial fibromatosis-Upper arm
0.000 0.995 0.005
M72.21 Plantar fascial fibromatosis-Shldr region
0.000 0.995 0.005
M72.20 Plantar fascial fibromatosis-Mult sites
0.000 0.995 0.005
C71.7 Brain stem
0.000 0.995 0.005
C71.6 Cerebellum
0.000 0.995 0.005
C71.5 Cerebral ventricle
0.000 0.995 0.005
K91.2 Postsurgical malabsorption, not elsewhere classified
0.000 0.995 0.005
K91.0 Vomiting following gastro-intestinal surgery
0.000 0.995 0.005
Q20-Q28 Congenital malformations of the circulatory system
0.005 0.995 0.000
M41.9 Scoliosis, unspecified
0.000 0.995 0.005
I42.9 Cardiomyopathy, unspecified
0.005 0.995 0.000
Q21.4 Aortopulmonary septal defect
0.004 0.995 0.000
Q21.2 Atrioventricular septal defect
0.004 0.995 0.000
M41.95 Scoliosis, unspecified (Thoracolumbar region)
0.000 0.995 0.005
Q21.3 Tetralogy of Fallot
0.004 0.995 0.000
M72.58 Fasciitis, not elsewhere classified-Other
0.000 0.995 0.004
T45.0 Antiallergic and antiemetic drugs
0.004 0.995 0.000
M72.59 Fasciitis, not elsewhere classified-Site unspec
0.000 0.995 0.004
M72.57 Fasciitis, not elsewhere classified-Ankle/Foot
0.000 0.995 0.004
M72.56 Fasciitis, not elsewhere classified-Lower Leg
0.000 0.995 0.004
M72.55 Fasciitis, not elsewhere classified-Pelvic/Thigh
0.000 0.995 0.004
M72.54 Fasciitis, not elsewhere classified-Hand
0.000 0.995 0.004
M72.53 Fasciitis, not elsewhere classified-Forearm
0.000 0.995 0.004
M72.52 Fasciitis, not elsewhere classified-Upper arm
0.000 0.995 0.004
M72.51 Fasciitis, not elsewhere classified-Shldr region
0.000 0.995 0.004
M72.50 Fasciitis, not elsewhere classified-Mult sites
0.000 0.995 0.004
M72.39 Nodular fasciitis-Site unspec
0.000 0.995 0.004
M72.38 Nodular fasciitis-Other
0.000 0.995 0.004
M72.37 Nodular fasciitis-Ankle/Foot
0.000 0.995 0.004
M72.36 Nodular fasciitis-Lower Leg
0.000 0.995 0.004
M72.35 Nodular fasciitis-Pelvic/Thigh
0.000 0.995 0.004
M72.34 Nodular fasciitis-Hand
0.000 0.995 0.004
M72.33 Nodular fasciitis-Forearm
0.000 0.995 0.004
M72.32 Nodular fasciitis-Upper arm
0.000 0.995 0.004
M72.31 Nodular fasciitis-Shldr region
0.000 0.995 0.004
M72.30 Nodular fasciitis-Mult sites
0.000 0.995 0.004
M72.49 Pseudosarcomatous fibromatosis (Site unspecified)
0.000 0.995 0.004
M72.48 Pseudosarcomatous fibromatosis (Other)
0.000 0.995 0.004
M72.47 Pseudosarcomatous fibromatosis (Ankle and foot)
0.000 0.995 0.004
M72.46 Pseudosarcomatous fibromatosis (Lower leg)
0.000 0.995 0.004
M72.45 Pseudosarcomatous fibromatosis (Pelvic region and thigh)
0.000 0.995 0.004
M72.44 Pseudosarcomatous fibromatosis (Hand)
0.000 0.995 0.004
M72.43 Pseudosarcomatous fibromatosis (Forearm)
0.000 0.995 0.004
M72.42 Pseudosarcomatous fibromatosis (Upper arm)
0.000 0.995 0.004
M72.41 Pseudosarcomatous fibromatosis (Shoulder region)
0.000 0.995 0.004
M72.40 Pseudosarcomatous fibromatosis (Multiple sites)
0.000 0.995 0.004
M72.69 Necrotizing fasciitis (Site unspecified)
0.000 0.995 0.004
M72.68 Necrotizing fasciitis (Other)
0.000 0.995 0.004
M72.67 Necrotizing fasciitis (Ankle and foot)
0.000 0.995 0.004
M72.66 Necrotizing fasciitis (Lower leg)
0.000 0.995 0.004
M72.65 Necrotizing fasciitis (Pelvic region and thigh)
0.000 0.995 0.004
M72.64 Necrotizing fasciitis (Hand)
0.000 0.995 0.004
M72.63 Necrotizing fasciitis (Forearm)
0.000 0.995 0.004
M72.62 Necrotizing fasciitis (Upper arm)
0.000 0.995 0.004
M72.61 Necrotizing fasciitis (Shoulder region)
0.000 0.995 0.004
M72.60 Necrotizing fasciitis (Multiple sites)
0.000 0.995 0.004
M72.89 Other fibroblastic disorders (Site unspecified)
0.000 0.995 0.004
M72.88 Other fibroblastic disorders (Other)
0.000 0.995 0.004
M72.87 Other fibroblastic disorders (Ankle and foot)
0.000 0.995 0.004
M72.86 Other fibroblastic disorders (Lower leg)
0.000 0.995 0.004
M72.85 Other fibroblastic disorders (Pelvic region and thigh)
0.000 0.995 0.004
M72.84 Other fibroblastic disorders (Hand)
0.000 0.995 0.004
M72.83 Other fibroblastic disorders (Forearm)
0.000 0.995 0.004
M72.82 Other fibroblastic disorders (Upper arm)
0.000 0.995 0.004
M72.81 Other fibroblastic disorders (Shoulder region)
0.000 0.995 0.004
M72.80 Other fibroblastic disorders (Multiple sites)
0.000 0.995 0.004
M72.99 Fibroblastic disorder, unspecified (Site unspecified)
0.000 0.995 0.004
M72.98 Fibroblastic disorder, unspecified (Other)
0.000 0.995 0.004
M72.97 Fibroblastic disorder, unspecified (Ankle and foot)
0.000 0.995 0.004
M72.96 Fibroblastic disorder, unspecified (Lower leg)
0.000 0.995 0.004
M72.95 Fibroblastic disorder, unspecified (Pelvic region and thigh)
0.000 0.995 0.004
M72.94 Fibroblastic disorder, unspecified (Hand)
0.000 0.995 0.004
M72.93 Fibroblastic disorder, unspecified (Forearm)
0.000 0.995 0.004
M72.92 Fibroblastic disorder, unspecified (Upper arm)
0.000 0.995 0.004
M72.91 Fibroblastic disorder, unspecified (Shoulder region)
0.000 0.995 0.004
M72.90 Fibroblastic disorder, unspecified (Multiple sites)
0.000 0.995 0.004
G20-G26 Extrapyramidal and movement disorders
0.004 0.996 0.000
E78.3 Hyperchylomicronaemia
0.004 0.996 0.000
C71.3 Parietal lobe
0.000 0.996 0.004
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.004 0.996 0.000
C71.8 Overlapping lesion of brain
0.000 0.996 0.004
Q21.1 Atrial septal defect
0.004 0.996 0.000
Q25.0 Patent ductus arteriosus
0.004 0.996 0.000
H11.0 Pterygium
0.000 0.996 0.004
K63.3 Ulcer of intestine
0.000 0.996 0.004
T43.3 Phenothiazine antipsychotics and neuroleptics
0.004 0.996 0.000
M72.19 Knuckle pads (Site unspecified)
0.000 0.996 0.004
M72.18 Knuckle pads-Other
0.000 0.996 0.004
M72.17 Knuckle pads (Ankle and foot)
0.000 0.996 0.004
M72.16 Knuckle pads-Lower Leg
0.000 0.996 0.004
M72.15 Knuckle pads-Pelvic/Thigh
0.000 0.996 0.004
M72.13 Knuckle pads-Forearm
0.000 0.996 0.004
M72.12 Knuckle pads-Upper arm
0.000 0.996 0.004
M72.11 Knuckle pads-Shldr region
0.000 0.996 0.004
M72.10 Knuckle pads (Multiple sites)
0.000 0.996 0.004
Q25.9 Congenital malformation of great arteries, unspecified
0.004 0.996 0.000
Q25.8 Other congenital malformations of great arteries
0.004 0.996 0.000
Q25.7 Other congenital malformations of pulmonary artery
0.004 0.996 0.000
Q25.5 Atresia of pulmonary artery
0.004 0.996 0.000
Q25.2 Atresia of aorta
0.004 0.996 0.000
M41.94 Scoliosis, unspecified (Thoracic region)
0.000 0.996 0.004
K52.8 Other specified non-infective gastro-enteritis and colitis
0.000 0.996 0.004
Q22 Congenital malformations of pulmonary and tricuspid valves
0.004 0.996 0.000
T43.9 Psychotropic drug, unspecified
0.004 0.996 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.004 0.996 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.004 0.996 0.000
C71.9 Brain, unspecified
0.000 0.996 0.004
G25.8 Other specified extrapyramidal and movement disorders
0.004 0.996 0.000
E78.9 Disorder of lipoprotein metabolism, unspecified
0.004 0.996 0.000
M41.97 Scoliosis, unspecified (Lumbosacral region)
0.000 0.996 0.004
G21 Secondary Parkinsonism
0.004 0.996 0.000
K91.3 Postoperative intestinal obstruction
0.000 0.996 0.004
M72.14 Knuckle pads (Hand)
0.000 0.996 0.003
Q25.3 Stenosis of aorta
0.004 0.996 0.000
G25 Other extrapyramidal and movement disorders
0.004 0.996 0.000
M41.90 Scoliosis, unspecified (Multiple sites in spine)
0.000 0.996 0.004
R27.8 Other and unspecified lack of coordination
0.004 0.996 0.000
R27 Other lack of coordination
0.004 0.996 0.000
E78.8 Other disorders of lipoprotein metabolism
0.004 0.996 0.000
E78.1 Pure hyperglyceridaemia
0.004 0.996 0.000
E78.6 Lipoprotein deficiency
0.004 0.996 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.004 0.996 0.000
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)
0.000 0.996 0.003
M41.93 Scoliosis, unspecified (Cervicothoracic region)
0.000 0.996 0.003
M41.92 Scoliosis, unspecified (Cervical region)
0.000 0.996 0.003
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)
0.000 0.996 0.003
E78.2 Mixed hyperlipidaemia
0.004 0.996 0.000
Q26 Congenital malformations of great veins
0.003 0.996 0.000
Q20 Congenital malformations of cardiac chambers and connexions
0.003 0.996 0.000
Q22.5 Ebstein's anomaly
0.003 0.996 0.000
T43.6 Psychostimulants with abuse potential
0.003 0.996 0.000
G25.9 Extrapyramidal and movement disorder, unspecified
0.004 0.996 0.000
G23 Other degenerative diseases of basal ganglia
0.003 0.997 0.000
J38.3 Other diseases of vocal cords
0.003 0.997 0.000
C09 Malignant neoplasm of tonsil
0.000 0.997 0.003
G26 Extrapyramidal and movement disorders in diseases classified elsewhere
0.003 0.997 0.000
G22 Parkinsonism in diseases classified elsewhere
0.003 0.997 0.000
E78.4 Other hyperlipidaemia
0.003 0.997 0.000
K91.5 Postcholecystectomy syndrome
0.000 0.997 0.003
Q27 Other congenital malformations of peripheral vascular system
0.003 0.997 0.000
Q23 Congenital malformations of aortic and mitral valves
0.003 0.997 0.000
G21.1 Other drug-induced secondary Parkinsonism
0.003 0.997 0.000
H11 Other disorders of conjunctiva
0.000 0.997 0.003
S62.50 Fracture of thumb (closed)
0.000 0.997 0.003
R69 Unknown and unspecified causes of morbidity
0.003 0.997 0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.000 0.997 0.003
J35.0 Chronic tonsillitis
0.003 0.997 0.000
G21.4 Vascular parkinsonism
0.003 0.997 0.000
H11.8 Other specified disorders of conjunctiva
0.000 0.997 0.003
Q22.9 Congenital malformation of tricuspid valve, unspecified
0.003 0.997 0.000
Q22.8 Other congenital malformations of tricuspid valve
0.003 0.997 0.000
Q22.6 Hypoplastic right heart syndrome
0.003 0.997 0.000
Q22.4 Congenital tricuspid stenosis
0.003 0.997 0.000
Q22.3 Other congenital malformations of pulmonary valve
0.003 0.997 0.000
Q22.2 Congenital pulmonary valve insufficiency
0.003 0.997 0.000
Q22.1 Congenital pulmonary valve stenosis
0.003 0.997 0.000
Q22.0 Pulmonary valve atresia
0.003 0.997 0.000
R60.0 Localised oedema
0.003 0.997 0.000
H11.1 Conjunctival degenerations and deposits
0.000 0.997 0.003
G25.1 Drug-induced tremor
0.003 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.